Tecnol v. Anago
This article was originally published in The Gray Sheet
Executive Summary
Federal District Court in Dallas rules that Tecnol is "not entitled to possess, directly or indirectly," rights to approximately 31% of Anago stock that Tecnol attempted to purchase in January 1992. In June, Tecnol sought court confirmation of its ownership of the stock ("The Gray Sheet" June 15, p. 23). Without the 533,000 disputed shares, Tecnol's stake in Anago is reduced to approximately 24%. Anago also is challenging Tecnol ownership of a "large" portion of the remaining stock, according to the company. In addition, Anago is seeking roughly $70 mil. in civil damages from Tecnol, alleging "tortious interference," breach of contract and civil conspiracy on the part of Tecnol. Remaining arguments in the dispute will be heard by the district court at a trial slated for September.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.